Form 4: MapLight Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
James Woodruff Lillie, Chief Scientific Officer of MapLight Therapeutics, Inc., sold 18,267 shares of common stock on July 15, 2026.
Summary
- Open-market sale: disposed of 2,238 Voting Common Stock at $36.00 ($80,568) on July 15, 2026; holds 240,491 after (Direct).
- Open-market sale: disposed of 5,393 Voting Common Stock at $36.99 ($199,487) on July 15, 2026; holds 235,098 after (Direct).
- Open-market sale: disposed of 12 Voting Common Stock at $37.54 ($450) on July 15, 2026; holds 235,086 after (Direct).
- Open-market sale: disposed of 5,009 Voting Common Stock at $36.45 ($182,578) on July 16, 2026; holds 230,077 after (Direct).
- Open-market sale: disposed of 3,526 Voting Common Stock at $37.26 ($131,379) on July 16, 2026; holds 226,551 after (Direct).
- Open-market sale: disposed of 12 Voting Common Stock at $37.96 ($456) on July 16, 2026; holds 226,539 after (Direct).
- Open-market sale: disposed of 2,077 Voting Common Stock at $37.90 ($78,718) on July 17, 2026; holds 224,462 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $673,636 of stock on the open market.
Insider Transactions
James Woodruff Lillie — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market sale | Voting Common Stock | 2,238 | $36 | $80.6K | 240,491 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 5,393 | $37 | $199.5K | 235,098 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 12 | $38 | $450 | 235,086 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 5,009 | $36 | $182.6K | 230,077 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 3,526 | $37 | $131.4K | 226,551 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 12 | $38 | $456 | 226,539 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 2,077 | $38 | $78.7K | 224,462 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market sale (2,238 shares) |
| 2026-07-15 | Open-market sale (5,393 shares) |
| 2026-07-15 | Open-market sale (12 shares) |
| 2026-07-16 | Open-market sale (5,009 shares) |
| 2026-07-16 | Open-market sale (3,526 shares) |
| 2026-07-16 | Open-market sale (12 shares) |
| 2026-07-17 | Open-market sale (2,077 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, James Woodruff Lillie
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.